Clinical Trial

A Study of BGM-2121 in Patients With Advanced Solid Tumors

Name: A Study of BGM-2121 in Patients With Advanced Solid Tumors — clinical trial record (NCT07346846)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is to explore the safety, tolerability, pharmacokinetics, and preliminary efficacy of BGM-2121 in adult patients with advanced solid tumors.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-22

Trial Details

NCT Number	NCT07346846
Lead Sponsor	BioGate Precision Medicine Corp.
Conditions	Advanced Solid Tumors
Enrollment	35 participants
Start Date	2026-03-10
Primary Completion	2027-11 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-21